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Introduction
Proadrenomedulin (proADM) is a novel prognostic bio-
marker employed in pneumonia and more recently in
severe sepsis and septic shock. Release kinetics of
proADM in this disease has not been studied. In this
research we analyze the variation in plasma levels of this
prohormone based upon the type of causative agent, the
site of infection and the presence of renal failure.
Methods
Plasmatic levels of ProADM were measured in 110 conse-
cutive patients admitted to the ICU with diagnosis of
severe sepsis or septic shock at admission. Clinical and
demographic data including age, gender, comorbidities,
APACHE II and SOFA scores were collected. Recruited
period over 12 months. Statistical analysis: c2 test for cate-
gorical variables; comparison of proADM levels based
upon etiologic agent, site of infection and presence of
renal failure were performed by using repeated measures
analysis of variance (ANOVA). Statistical significance:
p < 0.05.
Results
110 patients were recruited; Male 63 %, APACHE II score:
21; SOFA score: 8.5; Septic shock: 86%; ICU mortality:
32.7%; Respiratory focus: 49%; Urological focus: 22.7%;
Abdominal focus: 15%; Gram negatives: 33%; Gram posi-
tives: 30%; Virus: 13%; Fungi: 5.4%. As was expected, non
survivors showed significant higher plasma values of
proADM than survivors. The patients with pneumonia as
focus of sepsis and viruses as causative agent, showed
lower levels of plasma proADM than patients with another
focus and/or etiologic agent. In contrast, patients with
some degree of acute renal failure showed higher levels of
proADM.
See tables: plasmatic levels of proADM at admission
(mmol/L; median ± IQR). Statistical significance between
columns (p < 0.05) is shown as (*).
Conclusions
Prognostic value of proADM is preserved independent of
etiology, focus of infection and presence of renal failure in
severe sepsis and septic shock. When compared, severe
sepsis from respiratory tract showed lower values of
plasma proADM than other origins of sepsis. Alike, sepsis
caused by virus showed lower elevation of plasmatic levels
of this molecule. Finally presence of acute renal failure is
associated with higher plasmatic values of proADM in
both survivors and non-surviving septic patients. Larger
researches to confirm these findings are necessary.
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Table 1 proADM according etiology and survival.
Gram - Gram + Virus Fungi
Survivor 4.9 ± 3.9 3.9 ± 4.2 1.34 ± 0.8 * 3.0 ± 3.8
Non survivors 9.9 ± 5.4 8.5 ± 6 1.0 ± 0.3 * 5.8 ± 1.7
Table 2 proADM according focus and survival.
Pneumonia Urologic Abdominal Other
Survivors 1.1 ± 1.8 * 5.3 ± 3.7 5.5 ± 6.2 6.0 ± 4.2
Non survivors 5.1 ± 5 * 11.7 ± 4.8 10.6 ± 6.7 12.5 ± 0
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Table 3 proADM according renal failure and survival.
Renal failure No renal failure
Survivors 4.9 ± 4.2 * 1.02 ± 2.0 *
Non survivors 11.5 ± 5.0 * 3.5 ± 5.2 *
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